What is Nutromics?
Nutromics is at the forefront of revolutionizing diagnostics with its proprietary lab-on-a-patch technology, designed for Continuous Molecular Monitoring. This advanced solution aims to provide real-time health indicator tracking, offering crucial trend data that traditional diagnostic methods often miss. By enabling dynamic monitoring, Nutromics seeks to enhance patient outcomes and contribute to the reduction of healthcare costs, targeting both healthcare providers and individuals requiring continuous health insights.
How much funding has Nutromics raised?
Nutromics has raised a total of $19.7M across 2 funding rounds:
Unspecified
$5.7M
Other Financing Round
$14M
Unspecified (2021): $5.7M with participation from Artesian Capital Partners
Other Financing Round (2022): $14M led by Dexcom Ventures, Artesian Investments, and VU Venture Partners
Key Investors in Nutromics
VU Venture Partners
VU Venture Partners is a global venture capital fund specializing in early-stage investments across various sectors including healthcare. They are known for their selective investment approach and track record of supporting unicorns.
Artesian Capital Partners
Artesian Capital Partners provides integrated solutions in water and wastewater treatment, alongside innovative financing options, indicating a strategic interest in companies with robust technological and financial models.
Dexcom Ventures
Dexcom Ventures, likely associated with Dexcom, a leader in continuous glucose monitoring, suggests a strategic focus on companies advancing real-time health monitoring technologies.
What's next for Nutromics?
The recent major strategic investment signals a pivotal growth phase for Nutromics, likely enabling the company to scale its operations, further develop its groundbreaking lab-on-a-patch technology, and expand its market reach. This enterprise-level backing suggests confidence from investors in Nutromics' potential to disrupt the diagnostics sector and establish new standards in continuous health monitoring. Future developments may focus on clinical validation, regulatory approvals, and strategic partnerships to bring their innovative solutions to a wider patient population.
See full Nutromics company page
